I wish them luck. It should be interesting.

Seems several have attempted to develop CCR5 antagonists, but only Leronlimab (PRO 140) has demonstrated a lack known serious side effects.

https://en.wikipedia.org/wiki/CCR5_receptor_antagonist

I wonder if almost 10 years of safety data can be demonstrated by those chasing CYDY...